Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Clinical trial NCT01627340 · COMPLETED
Trial details
- NCT number
- NCT01627340
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-24
- Primary completion
- 2013-12-18
- Enrollment
- 667
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.